Am J Cardiol
- MEKARY W, Merchant FM
Multipoint Pacing for Cardiac Resynchronization: Is the MPP Juice Worth the
Battery Squeeze?
Am J Cardiol. 2024;216:98-99.
- AGARWAL S, Qamar U, Fujiwara Y, Guha A, et al
The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular
Outcomes in Patients with Cancer: A Systematic Review and Meta-Analysis.
Am J Cardiol. 2024 Feb 17:S0002-9149(24)00101.
Ann Thorac Surg
- PENG DM, Davies RR, Simpson KE, Shugh SB, et al
Seventh Annual Society of Thoracic Surgeons Pedimacs Report.
Ann Thorac Surg. 2024;117:690-703.
Cardiovasc Res
- RANGREZ AY, Frey N
Reverse cardio-oncology: is heart failure-mediated gut dysbiosis the mechanistic
driver of colorectal cancer progression?
Cardiovasc Res. 2024 Mar 28:cvae051. doi: 10.1093.
Circ Cardiovasc Qual Outcomes
- OHASHI K, Matsue Y, Maeda D, Fujimoto Y, et al
Impact of Multidomain Frailty on the Mode of Death in Older Patients With Heart
Failure: A Cohort Study.
Circ Cardiovasc Qual Outcomes. 2024 Mar 26:e010416.
Circulation
- BERG-HANSEN K, Gopalasingam N, Christensen KH, Ladefoged B, et al
Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart
Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind
Trial.
Circulation. 2024 Mar 27. doi: 10.1161/CIRCULATIONAHA.123.067971.
- GREEN JB, Everett BM, Ghosh A, Younes N, et al
Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2
Diabetes: A Comparative Effectiveness Study).
Circulation. 2024 Feb 12. doi: 10.1161/CIRCULATIONAHA.123.066604.
Clin Cardiol
- NABI R, Zahid T, Farooqi HA
Utilizing machine learning for predicting heart failure outcomes: A path toward
developing a patient-centered approach.
Clin Cardiol. 2024;47:e24260.
Coron Artery Dis
- WANG F, Li C, Zhang X
Sacubitril/valsartan improves the prognosis of acute myocardial infarction: a
meta-analysis.
Coron Artery Dis. 2024;35:231-238.
Eur Heart J
- PEDICINO D, Volpe M
Weekly journal scan: a hard RAFTing to improve long-term survival in heart
failure with severely reduced ejection fraction.
Eur Heart J. 2024 Mar 28:ehae167. doi: 10.1093.
- HENRY CM, Oseran AS, Zheng Z, Dong H, et al
Cardiovascular Hospitalizations and Mortality Among Adults Aged 25 to 64 years in
the United States.
Eur Heart J. 2023 Nov 11:ehad772. doi: 10.1093.
Eur J Heart Fail
- SUBRAMANIAN V, Keshvani N, Segar MW, Kondamudi NJ, et al
Association of global longitudinal strain by feature tracking cardiac magnetic
resonance imaging with adverse outcomes among community-dwelling adults without
cardiovascular disease: The Dallas Heart Study.
Eur J Heart Fail. 2024;26:208-215.
- GARCIA-PAVIA P, Grogan M, Kale P, Berk JL, et al
Impact of vutrisiran on exploratory cardiac parameters in hereditary
transthyretin-mediated amyloidosis with polyneuropathy.
Eur J Heart Fail. 2024;26:397-410.
- KRESOJA KP
Exercise haemodynamics in post-Fontan patients: Diastolic dysfunction, again and
again?
Eur J Heart Fail. 2024;26:324-326.
- MAEDER MT
Natriuretic peptides - Biomarker companions through thick and thin.
Eur J Heart Fail. 2024;26:270-273.
- MONDA E, Limongelli G
Expanding the knowledge on transthyretin p.V142I variant-related cardiomyopathy.
Eur J Heart Fail. 2024;26:394-396.
- SCISCIOLA L, Paolisso P, Belmonte M, Gallinoro E, et al
Myocardial sodium-glucose cotransporter 2 expression and cardiac remodelling in
patients with severe aortic stenosis: The BIO-AS study.
Eur J Heart Fail. 2024;26:471-482.
- COUGHLAN JJ, Rossello X
Anaemia in patients with cardiogenic shock complicating acute myocardial
infarction: Surrogate marker of poor outcome or therapeutic target?
Eur J Heart Fail. 2024;26:458-459.
- MERKELY B, Kosztin A
De novo versus upgrade cardiac resynchronization therapy: A different patient
population and outcome?
Eur J Heart Fail. 2024;26:521-522.
- MEEKERS E, Petit T, Dauw J, Gruwez H, et al
Analysing the accuracy of pressure measurements during exercise with pulmonary
artery pressure sensors - Insights from the ACTION-MEMS study.
Eur J Heart Fail. 2024;26:523-524.
- MIRANDA WR, Jain CC, Borlaug BA, Connolly HM, et al
Exercise catheterization in adults post-Fontan with normal and abnormal
haemodynamic criteria: Insights into normal Fontan physiology.
Eur J Heart Fail. 2024;26:314-323.
- OBRADOVIC D, Loncar G, Zeymer U, Poss J, et al
Impact of anaemia and iron deficiency on outcomes in cardiogenic shock
complicating acute myocardial infarction.
Eur J Heart Fail. 2024;26:448-457.
- RAZVI Y, Ioannou A, Patel RK, Chacko L, et al
Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid
cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?
Eur J Heart Fail. 2024;26:383-393.
- TRENSON S, Voros G, Martens P, Ingelaere S, et al
Long-term outcome after upgrade to cardiac resynchronization therapy: A
propensity score-matched analysis.
Eur J Heart Fail. 2024;26:511-520.
- RICCARDI M, Pagnesi M, Chioncel O, Mebazaa A, et al
Medical therapy of cardiogenic shock: Contemporary use of inotropes and
vasopressors.
Eur J Heart Fail. 2024;26:411-431.
- VAN DER LINDEN L, Karapinar-Carkit F, Forsyth P
The pharmacist ally in heart failure: Useful when involved. Letter regarding the
article 'Effective medications can work only in patients who take them:
Implications for post-acute heart failure care'.
Eur J Heart Fail. 2024 Mar 25. doi: 10.1002/ejhf.3217.
- DEHARO F, Grapsa J
Global longitudinal strain as a predictor of risk in patients with heart failure
with preserved ejection fraction: A deserved role?
Eur J Heart Fail. 2024 Mar 25. doi: 10.1002/ejhf.3211.
- LIM J, Hashemian M, Blechter B, Roger VL, et al
Pre-diagnostic free androgen and estradiol levels influence heart failure risk in
both women and men: A prospective cohort study in the UK Biobank.
Eur J Heart Fail. 2024 Mar 25. doi: 10.1002/ejhf.3189.
- DONAL E, Gegout L, Lee KC
More than just a clinical syndrome: Biomarkers and echocardiography should be
rapidly advised for anyone with suspected heart failure!
Eur J Heart Fail. 2024 Mar 27. doi: 10.1002/ejhf.3201.
Int J Cardiol
- YAO L, Gong X, Liu Y, Hao K, et al
The miR-195-3p/BDNF axis is a promising therapeutic for heart failure.
Int J Cardiol. 2024 Mar 22:131991. doi: 10.1016/j.ijcard.2024.131991.
- CHENG Y, Zhang Q
Comment on "Subclinical myocardial injury increases the risk of heart failure in
patients with and without type 2 diabetes post-acute coronary syndrome".
Int J Cardiol. 2024 Mar 26:131979. doi: 10.1016/j.ijcard.2024.131979.
J Am Coll Cardiol
- HAGE C, Sundstrom J, Lund LH
More evidence that heart failure with normal EF distinct from heart failure is
below normal EF.
J Am Coll Cardiol. 2024 Mar 12:S0735-1097(24)00990.
- FOA A, Vaduganathan M, Claggett BL, Pabon MA, et al
Sacubitril/Valsartan-Related Hypotension in Patients with Heart Failure and
Preserved or Mildly Reduced Ejection Fraction.
J Am Coll Cardiol. 2024 Mar 13:S0735-1097(24)00478.
- COTTER G, Davison B, Chioncel O
Enhanced Decongestive Therapy in Patients With Acute Heart Failure: JACC Review
Topic of the Week.
J Am Coll Cardiol. 2024;83:1243-1252.
J Card Fail
- RICCARDI M, Cikes M, Adamo M, Pagnesi M, et al
Functional mitral regurgitation and heart failure with preserved ejection
fraction: clinical implications and management.
J Card Fail. 2024 Mar 22:S1071-9164(24)00090.
- DE AVILA DX, di Candia AM, Moreira GR, Scaramussa VD, et al
Growth differentiation factor-15 (GDF-15) and clinical outcomes in patients with
chronic heart failure.
J Card Fail. 2024 Mar 26:S1071-9164(24)00106.
J Cardiovasc Pharmacol
- ZHANG X, Wang Z, Zhang L, Zhao X, et al
Comparative effectiveness and safety of intermittent, repeated or continuous use
of levosimendan, milrinone, or dobutamine in patients with advanced heart
failure: a network and single-arm meta-analysis.
J Cardiovasc Pharmacol. 2024 Mar 25. doi: 10.1097/FJC.0000000000001561.
PLoS One
- CHENG T, Yu D, Qiu X, OuYang W, et al
The relationship between a series of inflammatory markers on the risk of heart
failure in different gender groups: Analysis from NHANES 2015-2018.
PLoS One. 2024;19:e0296936.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016